BRIEF published on 03/03/2026 at 10:02, 12 days 22 hours ago Accor Discloses Share Capital and Voting Rights Voting Rights French Commercial Code Accor Shares Outstanding February 2026
REGULATED PRESS RELEASE published on 03/03/2026 at 09:57, 12 days 22 hours ago Disclosure of shares outstanding and voting rights - 03.03.2026 Accor discloses its share capital and voting rights as of February 28, 2026. Visit group.accor.com/en for more information Share Capital Voting Rights French Commercial Code Accor Disclosure
BRIEF published on 02/19/2026 at 07:35, 25 days ago Accor's 2025 Financial Performance Surpasses Expectations Revenue Growth Share Buyback Hospitality Sector Hotel Expansion Accor Financial Results
REGULATED PRESS RELEASE published on 02/19/2026 at 07:30, 25 days ago Full-Year 2025 Results: Solid results above 2025 guidance Accor reports solid full-year 2025 results, exceeding guidance. Strong performance driven by revPAR, net unit growth, and recurring EBITDA growth. Chairman Bazin emphasizes medium-term growth ambitions Accor Full-year Results RévPAR Net Unit Growth Recurring EBITDA
BRIEF published on 02/05/2026 at 11:35, 1 month 10 days ago Accor Announces Share Capital and Voting Rights Details Share Capital Voting Rights Accor Investor Information 2026 Disclosure
REGULATED PRESS RELEASE published on 02/05/2026 at 11:30, 1 month 10 days ago Disclosure of shares outstanding and voting rights - 05.02.2026 Accor releases regulated information disclosing share capital and voting rights. Visit https://group.accor.com/en for more details Share Capital Voting Rights Accor Regulated Information
BRIEF published on 01/22/2026 at 17:45, 1 month 24 days ago Accor Announces Share Capital and Voting Rights Update Voting Rights Accor Transparency Shares Outstanding 2025 Financial Update
REGULATED PRESS RELEASE published on 01/22/2026 at 17:40, 1 month 24 days ago Disclosure of shares outstanding and voting rights - 22.01.2026 Accor discloses share capital and voting rights information in accordance with Article L.233-8 II of the French Commercial Code Share Capital Voting Rights French Commercial Code Accor Disclosure
BRIEF published on 01/06/2026 at 10:22, 2 months 9 days ago Accor's Half-Year Liquidity Contract Report Liquidity Contract Accor Financial Report Share Trading 2025 Transactions
REGULATED PRESS RELEASE published on 01/06/2026 at 10:17, 2 months 9 days ago Half-year report on the liquidity contract Accor's liquidity contract details for the first half of 2025 with Rothschild Martin Maurel revealed €19.7 million in resources and extensive transactions Liquidity Contract Rothschild Martin Maurel Transactions Accor Resources
Published on 03/15/2026 at 23:25, 8 hours 38 minutes ago Tunkillia 'Phase 2' Resource Upgrade Drilling Begins
Published on 03/15/2026 at 18:00, 14 hours 3 minutes ago SEG Announced 2025 Annual Results Initiating First Special Dividend Distribution Payout Ratio Reached 88% Newly Signed Orders Exceeded RMB100-Billion Mark for the Second Consecutive Year
Published on 03/13/2026 at 23:00, 2 days 9 hours ago CORRECTION FROM SOURCE: EV Nickel Announces Maiden Mineral Resource Estimate for Gemini North Nickel Zone
Published on 03/13/2026 at 23:00, 2 days 9 hours ago Redwood AI Announces Platform Name Change and Appointment of Dr. Mark Dybul as Public Safety & Defense Advisor
Published on 03/13/2026 at 21:30, 2 days 10 hours ago Alset AI Announces Closing of Shares for Debt Transaction
Published on 03/16/2026 at 07:30, 33 minutes ago Mutares posts another record year: According to preliminary, unaudited figures, Mutares increases Group revenues and Holding’s net income in the fiscal year 2025 – medium-term targets raised to 25%...
Published on 03/16/2026 at 07:24, 39 minutes ago EQS-Adhoc: UBS AG: UBS publishes agenda for its Annual General Meeting on 15 April 2026
Published on 03/16/2026 at 07:05, 58 minutes ago Hypoport delivers solid gross margin growth and disproportionate EBIT increase in 2025
Published on 03/16/2026 at 07:02, 1 hour 1 minute ago Changes to the Board of Directors of Julius Baer Group
Published on 03/16/2026 at 07:00, 1 hour 3 minutes ago BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start
Published on 03/13/2026 at 19:50, 2 days 12 hours ago Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 2 days 13 hours ago Availability of the 2025 Universal Registration Document of OPmobility SE
Published on 03/13/2026 at 07:30, 3 days ago BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 3 days 14 hours ago NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS
Published on 03/12/2026 at 15:06, 3 days 16 hours ago FIERA MILANO: THE BOARD OF DIRECTORS APPROVES THE CONSOLIDATED RESULTS AS OF 31 DECEMBER 2025
